Viewing Study NCT04676360


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-03-07 @ 10:44 PM
Study NCT ID: NCT04676360
Status: TERMINATED
Last Update Posted: 2025-09-25
First Post: 2020-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma
Sponsor: Jacob Soumerai, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module